ATAI Life Sciences NV
NASDAQ:ATAI
ATAI Life Sciences NV
Cash from Operating Activities
ATAI Life Sciences NV
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Cash from Operating Activities
-$84.1m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bayer AG
XETRA:BAYN
|
Cash from Operating Activities
€5.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
0%
|
|
Merck KGaA
XETRA:MRK
|
Cash from Operating Activities
€3.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
|
MPH Health Care AG
XETRA:93M1
|
Cash from Operating Activities
€12m
|
CAGR 3-Years
56%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Cash from Operating Activities
€218.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Cash from Operating Activities
€24.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
See Also
What is ATAI Life Sciences NV's Cash from Operating Activities?
Cash from Operating Activities
-84.1m
USD
Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Cash from Operating Activities amounts to -84.1m USD.
What is ATAI Life Sciences NV's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-59%
Over the last year, the Cash from Operating Activities growth was 19%. The average annual Cash from Operating Activities growth rates for ATAI Life Sciences NV have been -59% over the past three years .